BV heads into its fiscal Q2 2026 earnings call today with a mixed print already on the tape: revenue blew past estimates, but the bottom line fell short.
The headline numbers split neatly between top and bottom. Revenue came in at $702.9 million, well above the $638.8 million consensus. Adjusted EPS of $0.09, however, missed the $0.10 estimate by a penny. More significantly, management raised full-year 2026 revenue guidance to $2.745–$2.795 billion, up from a prior range of $2.670–$2.730 billion and above the $2.715 billion Street estimate. The guidance lift is the key number here — it signals the revenue momentum is real enough for the company to embed it forward, even as margins remain under pressure.
Short sellers have been building positions modestly into the print, though the scale remains contained. Short interest rose roughly 20% over the past month to 3.9% of the free float — a steady drift higher rather than a conviction bet. Days to cover stand near 6.4 on the official FINRA reading, while borrow costs are near 0.45% and availability remains loose, suggesting no meaningful squeeze pressure in the lending market. Options positioning reinforces the cautious-but-not-bearish read: the put/call ratio has dropped sharply from above 1.5 in early April to 0.78 — well below the 20-day average of 1.12 — reflecting a pivot toward calls as the print approached.
The Street is split on whether the revenue strength translates into a rerate. Morgan Stanley holds an Equal-Weight with a $14 target — below the current price of $11.81 only after heavy declines from prior levels — while JP Morgan sits at Underweight with a $13 target. Goldman carries a Sell at $10.50. On the other side, Baird maintains Outperform and Loop Capital has a Buy, though both have trimmed targets progressively over the past year. The mean target of $16.64 implies roughly 41% return potential from current levels, though the consensus direction has been firmly downward since mid-2025. The EV/EBITDA multiple of 6.6x has compressed about 1% over the past month, reflecting a market that has been grading down the earnings quality story.
The earnings history adds nuance. The prior fiscal Q1 release produced virtually no price reaction on the day, while the December 2025 print delivered a 2.3% drop on the day and an 11.6% drawdown over the following five sessions. With revenue guidance now raised but per-share earnings still elusive, today's call is less about whether BV can grow the top line and more about whether management can demonstrate a credible path toward margin recovery.
See the live data behind this article on ORTEX.
Open BV on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
